Genomictree Market Cap

Genomictree has a market cap or net worth of 280.03 billion as of June 30, 2026. Its market cap has decreased by -12.22% in one year.

Market Cap

280.03B

Enterprise Value

205.01B

Revenue

3.83B

Ranking

n/a

PE Ratio

n/a

Stock Price

11,080.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 280.03B, an increase of 374.64%. That is a compound annual growth rate of 18.36%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	280.03B	-57.53%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MEDIPOST	370.14B
Proteina	345.40B
SillaJen	341.53B
BINEX	246.82B
GC Cell	238.93B
HLB Therapeutics	211.97B
EASY BIO,Inc.	207.42B
Anterogen.Co.,Ltd.	207.13B

Market Cap Rankings